When 12-year-olds receive a letter from the college nurse concerning the HPV vaccine, their reactions are sometimes mixed. Some students are concerned concerning the needle. Others wonder why they need a vaccine for something they've never heard of.
What a lot of them may not realize is that this routine school vaccination protects against a virus that may cause cancer later in life. For many students, this letter is the primary time they've encountered a remarkable idea: that a vaccine could help prevent cancer before it starts.
The evidence for this protection is now becoming clear. In our recent studywe analyzed long-term health data on girls and young women spanning nearly twenty years and located that the HPV vaccine greatly reduced the danger of cervical cancer.
This is very important because cervical cancer is one of the vital common cancers. Inspiring women around the worldDespite being largely preventable. Importantly, protection doesn't appear to weaken over time.
Human papilloma virus (HPV) is one of the vital common viruses on the earth. Most people will get it in some unspecified time in the future of their lives, often without even knowing it. In many cases, the body clears the virus naturally. But some kinds of HPV can stay within the body for years and slowly damage cells. Over time, it might result in cancer.
How does the HPV vaccine prevent cancer?
HPV causes just about all. Cervical cancer And may cause other cancers in each men and girls, including cancer Throat, anus, penis, vagina and vulva. Because these cancers often develop slowly, often years after infection, stopping the virus early is probably the most effective approach to prevent them.
This is strictly what the HPV vaccine is designed to do.
To understand how well the vaccine works in real life, we followed 926,362 girls and young women over the age of 18 in Sweden in a nationwide population-based study. Some had received the HPV vaccine, while others had not.
Over time, fewer people developed cervical cancer than those that weren't vaccinated. This shows that the vaccine helped. Save many people from getting cervical cancer..
We also found that age of vaccination is very important. Girls who received the vaccine before age 17 were much less prone to develop cervical cancer later in life. In fact, their risk was 4 times lower than that of unvaccinated girls. Those vaccinated later still had some protection, however the profit was smaller.
The reason is simple. The vaccine prevents HPV infection, but it surely cannot remove an existing infection. Vaccinating first, ideally before exposure to the virus, allows the immune system to develop. To build in advance security. This is why HPV vaccination is usually offered to young adolescents through school vaccination programs.
Long lasting protection
A standard query about vaccines is whether or not their protection wears off over time. The results of our study are satisfactory.
We followed the participants for 18 years after vaccination and located no evidence that protection decreased over time. Once the vaccine developed protection, it continued to work yr after yr. Long-lasting protection means the vaccine can protect against the virus through the years when it's most significant.
Many countries Now recommend HPV vaccination for each girls and boys, often in early adolescence. Vaccinating boys protects against HPV-related cancers and helps reduce the spread of the virus.
For many adults today, the HPV vaccine didn't exist once they were teenagers. Younger generations now have a robust opportunity: They can prevent certain cancers before they begin.
A future where most cancers are attributable to HPV. stopped It can start with a straightforward vaccine given in childhood.